Therapeutic Drug Monitoring for the Individualization of Docetaxel Dosing: A Randomized Pharmacokinetic Study

Engels FK, Loos WJ, van der Bol JM, et al. Clin Cancer Res. 2011;17:353-62

High and unpredictable interpatient variation can lead to unpredictable toxicity and lack of efficacy with docetaxel chemotherapy. This study demonstrated that therapeutic drug monitoring with a limited sampling strategy could be used to pharmacokinetically adjust doses. The variability of both docetaxel blood levels and the percentage decrease in neutrophil count were both reduced.

Start typing and press Enter to search